4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0000899243-20-030415
Chief Operating Officer acquired 3,746 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pedersen Anders Chief Operating Officer | 2020-11-02 | Conversion | +3,746 | 3,746 | D | ||
| Derivatives | |||||||
| Pedersen Anders Chief Operating Officer | 2020-06-24 | Grant or award · Stock Option (right to buy) | +142,983 | 142,983 | D | ||
| Pedersen Anders Chief Operating Officer | 2020-10-07 | Grant or award · Stock Option (right to buy) | +77,991 | 77,991 | D | ||
| Pedersen Anders Chief Operating Officer | 2020-11-02 | Conversion · Series C-1 Preferred Stock | −1,441 | 0 | D | ||
Loading xslF345X03/doc4.xml…